AZN

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change -1.14
Percentage change -1.55	%

Peers: ABBV PFE JNJ MRK NVS BMY GSK SNY LLY AMGN

| Held by: QQQ QQQM PVAL FVD TQQQ DIHP DFIC PPH AVDE QYLD

Index	NDX	P/E	31.91	EPS (ttm)	2.25	Insider Own	0.02%	Shs Outstand	3.10B	Perf Week	-5.77%
Market Cap	223.02B	Forward P/E	14.25	EPS next Y	5.05	Insider Trans	0.00%	Shs Float	3.10B	Perf Month	-4.62%
Income	7.04B	PEG	2.93	EPS next Q	1.10	Inst Own	16.80%	Short Float	0.49%	Perf Quarter	10.04%
Sales	54.07B	P/S	4.12	EPS this Y	8.99%	Inst Trans	-1.35%	Short Ratio	2.81	Perf Half Y	-6.77%
Book/sh	13.15	P/B	5.47	EPS next Y	12.82%	ROA	6.86%	Short Interest	15.24M	Perf Year	8.53%
Cash/sh	1.82	P/C	39.45	EPS next 5Y	10.88%	ROE	17.60%	52W Range	62.75 - 87.68	Perf YTD	9.76%
Dividend Est.	1.61 (2.24%)	P/FCF	21.69	EPS past 5Y	34.63%	ROI	10.28%	52W High	-17.98%	Beta	0.50
Dividend TTM	1.55 (2.16%)	Quick Ratio	0.74	Sales past 5Y	17.77%	Gross Margin	72.23%	52W Low	14.60%	ATR (14)	1.29
Dividend Ex-Date	Feb 21, 2025	Current Ratio	0.93	EPS Y/Y TTM	18.11%	Oper. Margin	20.17%	RSI (14)	36.47	Volatility	1.61% 1.39%
Employees	94300	Debt/Eq	0.74	Sales Y/Y TTM	18.03%	Profit Margin	13.01%	Recom	1.42	Target Price	88.85
Option/Short	Yes / Yes	LT Debt/Eq	0.68	EPS Q/Q	56.16%	Payout	66.98%	Rel Volume	1.15	Prev Close	73.05
Sales Surprise	4.67%	EPS Surprise	0.97%	Sales Q/Q	23.84%	Earnings	Feb 06 BMO	Avg Volume	5.43M	Price	71.91
SMA20	-5.33%	SMA50	-1.61%	SMA200	-3.81%	Trades		Volume	402,380	Change	-1.55%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-13-25	Upgrade	UBS	Neutral → Buy
Feb-12-25	Initiated	Morgan Stanley	Overweight
Nov-20-24	Upgrade	UBS	Sell → Neutral
Nov-06-24	Upgrade	Deutsche Bank	Sell → Hold
Sep-13-24	Downgrade	Deutsche Bank	Hold → Sell
May-30-24	Initiated	Goldman	Buy	$97
Apr-16-24	Upgrade	Deutsche Bank	Sell → Hold
Feb-08-24	Downgrade	Deutsche Bank	Hold → Sell
Jan-23-24	Initiated	Morgan Stanley	Overweight	$85
Jan-16-24	Resumed	UBS	Sell
Jan-03-24	Downgrade	Jefferies	Buy → Hold	$78.50 → $70
Dec-18-23	Initiated	HSBC Securities	Buy	$78
Sep-25-23	Upgrade	Jefferies	Hold → Buy	$66.50 → $80
Jul-14-23	Initiated	HSBC Securities	Buy
Jul-12-23	Upgrade	UBS	Neutral → Buy
Jul-05-23	Downgrade	Deutsche Bank	Buy → Hold
Apr-11-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jan-05-23	Initiated	BMO Capital Markets	Outperform	$82
Sep-15-22	Downgrade	Credit Suisse	Outperform → Neutral
Sep-07-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight

Show Previous Ratings

Today 09:00AM	Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca (PR Newswire)
08:17AM	Merck Inks $2B Licensing Deal With Chinese Biotech for Oral Heart Drug (Zacks)
Mar-25-25 07:02PM	New study results reinforce TAGRISSO (osimertinib) as the backbone therapy for EGFR-mutated lung cancer across stages and settings (Business Wire)
07:47AM	Fidelity Freedom Income Fund Q4 2024 Review (SeekingAlpha)
Mar-24-25 01:56PM	Argenx: The Magic May Be Already Priced In (SeekingAlpha)
01:12PM	Loading…
01:12PM	Assemblin to upgrade AstraZenecas Gärtuna plant in Sweden (World Construction Network)
08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
05:20AM	AstraZeneca to invest $2.5bn in R&D centre in China (Pharmaceutical Technology)
Mar-23-25 06:05AM	Forget the Correction: This Stock Is Defying the Sell-Off, and There Might Be More Upside Ahead (Motley Fool)
Mar-21-25 12:26PM	Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals (Zacks)
11:30AM	Krystal Biotech (KRYS) Up 3.3% Since Last Earnings Report: Can It Continue? (Zacks)
10:39AM	AstraZeneca to invest £2bn in Beijing amid China investigation (The Telegraph)
10:19AM	Micron, Johnson & Johnson, AstraZeneca: Top Stocks (Yahoo Finance Video)
09:25AM	AstraZeneca to Invest $2.5 Billion in China Amid Probes (The Wall Street Journal)
08:15AM	AstraZeneca deepens China investment; Editas loses CFO to Dyne (BioPharma Dive)
07:57AM	Loading…
07:57AM	AstraZeneca Invests $2.5 Billion in R&D Center in China (The Wall Street Journal)
07:48AM	AstraZeneca Invests $2.5 Billion in Beijing Hub Amid Probe (Bloomberg)
07:30AM	AstraZeneca to invest $2.5bn in China after scandal (Financial Times)
07:21AM	Merck Vs. Bristol-Myers Squibb: Which Pharma Stock Should You Buy (SeekingAlpha)
07:03AM	AstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandals (Reuters)
Mar-20-25 08:58AM	Here's Why Parnassus Growth Equity Fund Decided to Sell AstraZeneca PLC (AZN) (InsiderMonkey)
Mar-19-25 09:21PM	BlackRock Global Dividend Fund Q4 2024 Commentary (SeekingAlpha)
06:15PM	Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
10:18AM	AstraZeneca (AZN): Among the Best Diabetes Stocks to Buy According to Billionaires (Insider Monkey)
Mar-18-25 08:47AM	Is AstraZeneca (AZN) the Best European Stock to Buy According to Billionaires? (Insider Monkey)
08:18AM	AstraZenecas $1bn hypoparathyroidism drug achieves success at Phase III (Clinical Trials Arena)
08:05AM	Stoke CEO exits; Medicare drug price talks advance (BioPharma Dive)
05:32AM	AstraZeneca and Alteogen agree on ALT-B4 platform tech (Pharmaceutical Technology)
Mar-17-25 08:04AM	IgniteData launches cutting edge data integration platform for clinical trials at Cambridge University Hospitals (PR Newswire)
07:58AM	Eventful Monday For AstraZeneca - What's Going On? (Benzinga)
05:28AM	Loading…
05:28AM	AstraZeneca adds in vivo cell therapy capabilities with EsoBiotech deal (BioPharma Dive)
03:47AM	AstraZeneca Buys Belgian EsoBiotec for Up to $1 Billion to Boost Cell-Therapy Portfolio (The Wall Street Journal)
03:06AM	AstraZeneca boosts cancer therapies push with $1 billion EsoBiotec buy (Reuters)
03:00AM	EsoBiotec to Be Acquired by AstraZeneca to Advance Cell Therapy Ambition (GlobeNewswire)
Mar-14-25 04:02PM	AstraZeneca Stock Scores RS Rating Upgrade (Investor's Business Daily)
03:10PM	Analyst Report: AstraZeneca PLC (Morningstar Research)
01:39PM	INOVIOs Covid-19 dMAb maintains in-vivo detection in 100% participants (Clinical Trials Arena)
01:29PM	AstraZeneca director says AI must be a thought partner in drug discovery (Pharmaceutical Technology)
12:00PM	AstraZeneca and Erin Andrews team up to inspire fans to Get Body Checked Against Cancer (Business Wire)
Mar-13-25 11:55AM	AstraZeneca Stock Nears Buy Point After Long Run In Declining Market (Investor's Business Daily)
Mar-12-25 06:15PM	Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know (Zacks)
04:09PM	Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion (Investor's Business Daily)
Mar-10-25 07:18PM	AstraZeneca and Ionis win EU approval for ATTR polyneuropathy (Pharmaceutical Technology)
06:04AM	AstraZeneca reports positive outcomes from trial of Imfinzi (Clinical Trials Arena)
Mar-07-25 07:54AM	AstraZeneca's Imfinzi-Based Regimen Shows Improved Event-Free Survival In Early-Stage Gastric Cancer Patients (Benzinga)
07:00AM	IMFINZI (durvalumab)-based regimen demonstrated statistically significant and clinically meaningful improvement in event-free survival in resectable early-stage gastric and gastroesophageal junction cancers (Business Wire)
Mar-06-25 06:15PM	Astrazeneca (AZN) Stock Moves -0.63%: What You Should Know (Zacks)
Mar-05-25 09:45AM	What Trump's next batch of tariffs could mean for pharma industry (Yahoo Finance Video)
02:04AM	Compugen Ltd (CGEN) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges (GuruFocus.com)
Mar-04-25 06:49AM	EU set to approve AstraZenecas Imfinzi-chemo combo for NSCLC (Pharmaceutical Technology)
05:30AM	Daiichi Sankyo and AstraZenecas Enhertu shows OS improvements in Phase III trial (Clinical Trials Arena)
Mar-03-25 07:44AM	Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP (Clinical Trials Arena)
Mar-02-25 11:48AM	Is AstraZeneca PLC (AZN) The Best Immunology Stock To Buy Now? (Insider Monkey)
Mar-01-25 05:30PM	Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps (Business Wire)
02:55PM	Is AstraZeneca PLC (AZN) the Best Weight Loss Drug Stock to Buy According to Analysts? (Insider Monkey)
Feb-28-25 06:15PM	Here's Why Astrazeneca (AZN) Gained But Lagged the Market Today (Zacks)
07:00AM	Drug Stocks Are the New Safe Bet in a Shaky Market (The Wall Street Journal)
Feb-27-25 05:38AM	AstraZeneca reports positive outcomes from breast cancer combo therapy trial (Clinical Trials Arena)
Feb-26-25 11:05AM	AstraZeneca PLC (AZN): One of the Best Vaccine Stocks to Buy According to Hedge Funds (Insider Monkey)
07:04AM	AstraZeneca breast cancer drug shows positive results, shares up (Investing.com)
07:00AM	Camizestrant demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival in 1st-line advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial (Business Wire)
06:11AM	AstraZenecas next breast cancer drug; Madrigals accelerating MASH launch (BioPharma Dive)
Feb-25-25 02:18PM	Final Trades: Starbucks, Astrazeneca, Western Union and the IYR (CNBC TV)
Feb-24-25 05:27PM	AstraZeneca PLC (AZN): A High Growth Mega Cap Stock You Can Buy and Hold for the Next 5 Years (Insider Monkey)
04:00AM	Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing (PR Newswire)
Feb-22-25 11:22PM	AstraZeneca PLC (AZN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts (Insider Monkey)
05:47AM	3 Magnificent Growth Stocks to Buy Right Now (Motley Fool)
Feb-20-25 04:27PM	AstraZeneca PLC (AZN): Among the Best Global Stocks to Buy According to Hedge Funds (Insider Monkey)
04:02PM	FibroGen sells China unit to AstraZeneca for $160m (Pharmaceutical Technology)
07:48AM	Heres Why AstraZeneca PLC (AZN) Traded Lower in Q4 (Insider Monkey)
06:40AM	AstraZeneca boosts China presence with FibroGen's anemia drug in $160 million deal (Reuters)
05:55AM	AstraZeneca deepens China presence with FibroGen deal (BioPharma Dive)
04:16AM	Q4 2024 Ionis Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-17-25 10:15AM	AstraZenecas Imfinzi bladder cancer regimen improves survival in Phase III trial (Clinical Trials Arena)
Feb-15-25 11:15AM	AstraZeneca: IMFINZI improved event-free survival, OS across MIBC (TipRanks)
08:45AM	2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025 (Motley Fool)
Feb-14-25 11:10AM	IMFINZI (durvalumab) perioperative regimen improved event-free survival and overall survival across muscle-invasive bladder cancer patients regardless of complete pathology response status in post-hoc exploratory analysis of NIAGARA Phase III trial (Business Wire)
06:30AM	Is AstraZeneca PLC (AZN) the Best Foreign Dividend Stock to Buy According to Analysts? (Insider Monkey)
05:45AM	Shareholders of AstraZeneca PLC Should Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights - AZN (PR Newswire)
Feb-12-25 12:43AM	AstraZeneca PLC (AZN): Among the Best International Dividend Stocks to Buy Now (Insider Monkey)
Feb-11-25 02:36PM	Is AstraZeneca PLC (AZN) the Safest Dividend Stock in the UK? (Insider Monkey)
01:55PM	Final Trades: Trade Desk, Leidos Holdings, Astrazeneca and Devon Energy (CNBC TV)
05:45AM	AstraZeneca PLC Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights - AZN (PR Newswire)
Feb-10-25 08:17PM	Analyst Report: AstraZeneca PLC (Morningstar Research)
Feb-07-25 02:06AM	AstraZeneca PLC (AZN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges (GuruFocus.com)
Feb-06-25 07:36PM	Analyst Report: AstraZeneca PLC (Morningstar Research)
05:00PM	Why AstraZeneca Topped the Market on Thursday (Motley Fool)
04:15PM	AstraZenecas shares rise as it addresses China investigation (Pharmaceutical Technology)
02:41PM	Pound plunges as Bank of England cuts rates and hints at more to come (The Telegraph)
02:00PM	AstraZeneca Plc (AZN) Q4 2024 Earnings Call Transcript (Motley Fool)
12:02PM	AstraZeneca Could Pay $4.5 Million In China Scandal. Here's Why Shares Jumped. (Investor's Business Daily)
11:51AM	AstraZenecas diabetes drug fails to slow Parkinsons progression in UCL trial (Clinical Trials Arena)
09:50AM	Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term (Zacks)
09:46AM	AstraZeneca boss denies falling out with Labour despite scrapping £450m factory (The Telegraph)
09:30AM	Astrazeneca (AZN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
09:02AM	AstraZeneca Bounds Higher On Fourth-Quarter Beat, Upbeat Guidance (Investor's Business Daily)
08:40AM	AstraZeneca Q4 Earnings: Revenue And EPS Beat On Higher Cancer And Respiratory Drug Sales, Faces $4.5 Million Potential Fine In China (Benzinga)
07:00AM	AstraZenecas Full Year and Q4 2024 results (Business Wire)
06:01AM	AstraZeneca Expects Revenue, Earnings Growth Despite Sales Drop in China (The Wall Street Journal)
05:08AM	Astrazeneca: Q4 Earnings Snapshot (Associated Press Finance)

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Astrazeneca plc ADR

Upgrade your FINVIZ experience